In order to test the degradation pathway of TIM-4 after the removal of N-glycosylation, TIM-4 or N291Q were transfected into NSCLC cells and the cells were treated with Eer I, inhibitor of ERAD, then the cell lysates were used for western blot analysis. Here, TIMD4 is linked to non-small cell lung carcinoma.